|
Showing the most relevant articles for your search:NASDAQ:FLKS 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | 2019/11/13 | 06 : 35 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/10/28 | 21 : 33 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/10/28 | 21 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/10/23 | 05 : 23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/19 | 06 : 03 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/19 | 05 : 56 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/17 | 06 : 16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/14 | 07 : 32 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/14 | 07 : 31 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/13 | 19 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/13 | 19 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/09/13 | 19 : 16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/08/12 | 21 : 17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/30 | 06 : 28 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/30 | 06 : 28 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/30 | 06 : 09 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/25 | 05 : 49 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/24 | 08 : 54 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/24 | 08 : 54 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/24 | 08 : 53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/24 | 08 : 50 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/24 | 08 : 49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/23 | 06 : 09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/19 | 06 : 06 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/18 | 06 : 03 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/16 | 05 : 18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/16 | 05 : 16 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/13 | 05 : 16 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/13 | 05 : 05 | Business Wire | Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting | NASDAQ:FLKS | Flex Pharma, Inc. |
2019/07/02 | 04 : 04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:FLKS |
|